Artificial intelligence (AI)-generated content on glucagon-like peptide-1 receptor agonists (GLP-1RAs) gave informationally detailed responses, but its readability remains suboptimal for many patients. Incorporating literacy-sensitive design principles into AI... ...

请注册登录后继续浏览